SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001818382-22-000164
Filing Date
2022-09-19
Accepted
2022-09-19 16:41:43
Documents
2
Period of Report
2022-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166362008567891.html 3  
1 FORM 3 wf-form3_166362008567891.xml 3 1727
2 POA DOCUMENT - CBG ex-24.htm EX-24 3290
  Complete submission text file 0001818382-22-000164.txt   6474
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3185 SCENIC DRIVE NAPA CA 94558
Business Address
Green Charles Bruce (Reporting) CIK: 0001945398 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39532 | Film No.: 221251027